Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells

Neoplasia

Volumn 12, Issue 8, 2010, Pages 618-627

  Hawcroft, Gillian ^a   Loadman, Paul M ^b   Belluzzi, Andrea ^c   Hull, Mark A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLOOXYGENASE 2; ICOSAPENTAENOIC ACID; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROSTAGLANDIN E3; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL STRAIN HEK293; COLORECTAL CANCER; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME SUBSTRATE COMPLEX; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 77956040136     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.10388     Document Type: Article

References (42)

1. Eisinger AL, Prescott SM, Jones DA, and Stafforini DM (2007). The role of cyclooxygenase-2 and prostaglandins in colon cancer. Prostaglandins Other Lipid Mediat 82, 147-154.
2. Wang D and DuBois RN (2006). Prostaglandins and cancer. Gut 55, 115-122.
3. 2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ. Cancer Cell 6, 285-295.
4. 2 administration. Carcinogenesis 24, 985-990.
5. Chapkin RS, McMurray DN, and Lupton JR (2007). Colon cancer, fatty acids and anti-inflammatory compounds. Curr Opin Gastroenterol 23, 48-54.
6. Calviello G, Serini S, and Piccioni E (2007). n-3 Polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved. Curr Med Chem 14, 3059-3069.
7. Smith WL (2005). Cyclooxygenases, peroxide tone and the allure of fish oil. Curr Opin Cell Biol 17, 174-182.
8. 3 from eicosapentaenoic acid in human lung cancer cells. J Lipid Res 45, 1030-1039.
9. Funahashi H, Satake M, Hasan S, Sawai H, Newman RA, Reber HA, Hines OJ, and Eibl G (2008). Opposing effects of n-6 and n-3 polyunsaturated fatty acids on pancreatic cancer growth. Pancreas 36, 353-362.
10. 3. Carcinogenesis 29, 790-796.
11. Sugimoto Y and Narumiya S (2007). Prostaglandin E receptors. J Biol Chem 282, 11613-11617.
12. Hull MA, Ko SCW, and Hawcroft G (2004). Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? Mol Cancer Ther 3, 1031-1039.
13. Chell SD, Witherden IR, Dobson RR, Moorghen M, Herman AA, Qualtrough D, Williams AC, and Paraskeva C (2006). Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence. Cancer Res 66, 3106-3113.
14. Hawcroft G, Ko CWS, and Hull MA (2007). Prostaglandin E2-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells. Oncogene 26, 3006-3019.
15. Yang L, Huang Y, Porta R, Yanagisawa K, Gonzalez A, Segi E, Johnson DH, Narumiya S, and Carbone DP (2006). Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism. Cancer Res 66, 9665-9672.
16. Lawson LD and Hughes BG (1988). Human absorption of fish oil fatty acids as triacylglyercols, free acids or ethyl esters. Biochem Biophys Res Commun 152, 328-335.
17. West NJ, Clark SK, Phillips RKS, Hutchinson JM, Leicester RJ, Belluzzi A, and Hull MA (2010). Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. Gut, E-pub ahead of print March.
18. Fenwick SW, Toogood GJ, Lodge JPA, and Hull MA (2003). The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases. Gastroenterology 125, 716-729.
19. Shiff SJ, Koutsos MI, Qiao L, and Rigas B (1996). Nonsteroidal anti-inflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp Cell Res 222, 179-188.
20. Elder DJE, Halton DE, Hague A, and Paraskeva C (1997). Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin Cancer Res 3, 1679-1683.
21. Piazza GA, Rahm AK, Finn TS, Li H, Stoumen AL, Pamukcu R, and Ahnen DJ (1997). Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest and p53 induction. Cancer Res 57, 2452-2459.
22. Qia L, Shiff SJ, and Rigas B (1997). Sulindac sulphide inhibits the proliferation of colon cancer cells: diminished expression of the proliferation markers PCNA and Ki-67. Cancer Lett 115, 229-234.
23. Smith M-L, Hawcroft G, and Hull MA (2000). The effect of non-steroidal antiinflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. Eur J Cancer 36, 664-674.
24. Ko SCW, Chapple KS, Hawcroft G, Coletta PL, Markham AF, and Hull MA (2002). Paracrine cyclooxygenase-2-mediated signalling by macrophages promotes tumorigenic progression of intestinal epithelial cells. Oncogene 21, 7175-7186.
25. Gardner SH, Hawcroft G, and Hull MA (2004). Effect of nonsteroidal antiinflammatory drugs of β-catenin protein levels and catenin-related transcription in human colorectal cancer cells. B J Cancer 91, 153-163.
26. 2 synthesis in healthy humans and those with lung cancer. Anal Biochem 334, 266-275.
27. Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, Maggiano N, Tringali G, Navarra P, Ranelletti FO, and Palozza P (2004). n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1α induction pathway. Carcinogenesis 25, 2303-2310.
28. 2 promotes colon cancer cell growth through a novel Gs-axin-β-catenin signaling axis. Science 310, 1504-1510.
29. Shoji Y, Takahashi M, Kitamura T, Watanabe K, Kawamori T, Maruyama T, Sugimoto Y, Negishi M, Narumiya S, Sugimura T, et al. (2004). Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development. Gut 53, 1151-1158.
30. Courtney ED, Matthews S, Finlayson C, Di Pierro D, Belluzzi A, Roda E, Kang JY, and Leicester RJ (2007). Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int J Colorectal Dis 22, 765-776.
31. Wada M, DeLong CJ, Hong YH, Rieke CJ, Song I, Sidhu RS, Chong Y, Warnock M, Schmaier AH, Yokoyama C, et al. (2007). Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem 282, 22254-22266.
32. Belury MA, Patrick KE, Locniskar M, and Fischer SM (1989). Eicosapentaenoic acid and arachidonic acid: comparison of metabolism and activity in murine epidermal cells. Lipids 24, 423-429.
33. Hatala MA, Rayburn J, and Rose DP (1994). Comparison of linoleic acid and eicosapentaenoic acid incorporation into human breast cancer cells. Lipids 29, 831-837.
34. Tull SP, Yates CM, Maskrey BH, O'Donnell VB, Madden J, Grimble RF, Calder PC, Nash GB, and Rainger GE (2009). Omega-3 fatty acids and inflammation. Novel interactions reveal a new step in neutrophil recruitment. PLoS Biol 7, e1000177.
35. Arterburn LM, Bailey Hall E, and Oken H (2006). Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83(suppl), 1467S-1476S.
36. 2. BMC Cancer 8, 380.
37. Denkins Y, Kempf D, Ferniz M, Nileshwar S, and Marchetti D (2005). Role of ω-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolismin brain-metastatic melanoma. J Lipid Res 46, 1278-1284.
38. Bagga D, Wang L, Farias-Eisner R, Glaspy JA, and Reddy ST (2003). Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci USA 100, 1751-1756.
39. 2 stimulate the growth of normal but not tumour mouse ma mary epithelial cells. Prostaglandins Leukot Essent Fatty Acids 51, 437-443.
40. 2 synthesis and cytotoxicity in human colorectal carcinoma cell lines. Carcinogenesis 24, 385-392.
41. Aronson WJ, Glaspy JA, Reddy ST, Reese D, Heber D, and Bagga D (2001). Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer. Urology 58, 283-288.
42. Cao J, Schwichtenberg KA, Hanson NQ, and Tsai MY (2006). Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 52, 2265-2272.